Soleno Therapeutics Inc. (SLNO): Skating on Thin Ice? We Know the Answer

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Soleno Therapeutics Inc. (NASDAQ:SLNO) went down by -4.10% from its latest closing price compared to the recent 1-year high of $4.39. The company’s stock price has collected -7.87% of loss in the last five trading sessions. Press Release reported on 03/09/21 that Soleno to Participate in the 31st Annual Oppenheimer Healthcare Conference

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Is It Worth Investing in Soleno Therapeutics Inc. (NASDAQ :SLNO) Right Now?

Plus, the 36-month beta value for SLNO is at 0.44. Opinions of the stock are interesting as 3 analysts out of 3 who provided ratings for Soleno Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.


The average price from analysts is $7.00. SLNO currently public float of 66.60M and currently shorts hold a 2.60% ratio of that float. Today, the average trading volume of SLNO was 1.78M shares.

SLNO’s Market Performance

SLNO stocks went down by -7.87% for the week, with a monthly drop of -15.22% and a quarterly performance of -43.48%, while its annual performance rate touched -46.58%. The volatility ratio for the week stands at 6.09% while the volatility levels for the past 30 days are set at 8.03% for Soleno Therapeutics Inc.. The simple moving average for the period of the last 20 days is -17.31% for SLNO stocks with a simple moving average of -41.24% for the last 200 days.

Analysts’ Opinion of SLNO

Many brokerage firms have already submitted their reports for SLNO stocks, with Guggenheim repeating the rating for SLNO by listing it as a “Buy.” The predicted price for SLNO in the upcoming period, according to Guggenheim is $8 based on the research report published on September 29th of the previous year 2020.

Craig Hallum, on the other hand, stated in their research note that they expect to see SLNO reach a price target of $8. The rating they have provided for SLNO stocks is “Buy” according to the report published on January 10th, 2020.

Oppenheimer gave a rating of “Outperform” to SLNO, setting the target price at $10 in the report published on December 23rd of the previous year.

SLNO Trading at -44.26% from the 50-Day Moving Average

After a stumble in the market that brought SLNO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -73.35% of loss for the given period.

Volatility was left at 8.03%, however, over the last 30 days, the volatility rate increased by 6.09%, as shares sank -16.43% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -42.93% lower at present.

During the last 5 trading sessions, SLNO fell by -7.87%, which changed the moving average for the period of 200-days by -39.06% in comparison to the 20-day moving average, which settled at $1.4035. In addition, Soleno Therapeutics Inc. saw -39.38% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at SLNO starting from Harris William G, who sale 2,497 shares at the price of $1.74 back on Oct 30. After this action, Harris William G now owns 66,271 shares of Soleno Therapeutics Inc., valued at $4,345 using the latest closing price.

Sinclair Andrew, the Director of Soleno Therapeutics Inc., purchase 3,333,330 shares at $1.65 during a trade that took place back on Jun 26, which means that Sinclair Andrew is holding 10,302,602 shares at $5,499,994 based on the most recent closing price.

Stock Fundamentals for SLNO

The total capital return value is set at -104.84, while invested capital returns managed to touch -81.46. Equity return is now at value -61.90, with -39.80 for asset returns.

Based on Soleno Therapeutics Inc. (SLNO), the company’s capital structure generated 0.32 points at debt to equity in total, while total debt to capital is 0.32.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

The liquidity ratio also appears to be rather interesting for investors as it stands at 5.83.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Important Earnings

Insider Watchlist

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.